Evidence map›Paper›PMID 37251871›Full record

ArticleHeliyon2023

Modeling and

Maysa E Moharam, Magda A El-Bendary, Mostafa M Abo Elsoud, Fawkia El- Beih, Saadia M Hassnin, Abeer Salama, Enayat A Omara, Nora N Elgamal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maysa E MoharamMicrobial Chemistry Department, Biotechnology Research Institute, National Research Centre, Egypt.
Magda A El-BendaryMicrobial Chemistry Department, Biotechnology Research Institute, National Research Centre, Egypt.
Mostafa M Abo ElsoudMicrobial Biotechnology Department, National Research Centre, Egypt.
Fawkia El- BeihFaculty of Science, Ain Shams University, Cairo, Egypt.
Saadia M HassninFaculty of Science, Ain Shams University, Cairo, Egypt.
Abeer SalamaPharmacology Department, National Research Centre, Egypt.
Enayat A OmaraPathology Department, National Research Centre, Egypt.
Nora N ElgamalMicrobial Chemistry Department, Biotechnology Research Institute, National Research Centre, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood clot formation increases cases of myocardial infarction (AMI) and stroke, thus urges directing much research works for treatment and prevention of the causes. One of these directions is the microbial production of fibrinolytic enzymes as thrombolytic agents. In the current work,

Indexed as

Acute toxicityBacillus subtilisBlood clotCentral composite design (CCD)Fibrinolytic enzymesHyper coagulable disorder

Identifiers

PMID37251871
PMCPMC10220232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.